SPRY3 and osteosarcoma: If a Spry3 protein is mutated to a version where the tyrosine in the N-terminal box is substituted by a phenylalanine mimicking a phosphorylation negative protein, its ectopic expression is able to inhibit cell migration of the osteosarcoma-derived U2OS cells.